• Explore /
  • Poster
  • / Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery followed by adjuvant docetaxel and S-1 for patients with large type 3 or type 4 gastric cancer: Short-term outcomes of the phase II OGSG1902 trial.

Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery followed by adjuvant docetaxel and S-1 for patients with large type 3 or type 4 gastric cancer: Short-term outcomes of the phase II OGSG1902 trial.

Abstract Poster

Authors

null

Hiromichi Miyagaki

Osaka Rosai Hospital, Sakai, Japan

Hiromichi Miyagaki , Masahiro Goto , Shunji Endo , Ryo Tanaka , Takeshi Omori , Junji Kawada , Naoki Takahashi , Toru Masuzawa , Haruna Furukawa , Yuya Sato , Takeshi Kato , Kazumasa Fujitani , Hisato Kawakami , Daisuke Sakai , Yukinori Kurokawa , Toshimasa Tsujinaka , Toshio Shimokawa , Taroh Satoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

jRCTs051190060

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 4031)

DOI

10.1200/JCO.2024.42.16_suppl.4031

Abstract #

4031

Poster Bd #

11

Abstract Disclosures

Similar Posters

First Author: Daisuke Takahari

First Author: Rixci Ramirez

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).

First Author: Izuma Nakayama

First Author: Wataru Ichikawa